Literature DB >> 6751733

The dawn phenomenon, an early morning glucose rise: implications for diabetic intraday blood glucose variation.

M I Schmidt, A Hadji-Georgopoulos, M Rendell, S Margolis, A Kowarski.   

Abstract

Eleven insulin-dependent (type I) diabetic subjects were studied during a 24-h period to assess intraday blood glucose (BG) variation and related free insulin (FI) levels. Ten patients exhibited the dawn phenomenon, a rise in early morning fasting blood glucose (123 +/- 81.1 m/dl; mean +/- SD). This increase was positively and significantly correlated with the morning postprandial BG peak (r = 0.723; P = 0.012). FI/BG ratios were highest during the night (0.717 and 0.666 at 2200 and 0400 h, respectively) and lowest during the early morning (0.294 at 0800 h) (P less than 0.01). Three of the four observed hypoglycemic episodes occurred during the period when free insulin levels were high relative to BG. We conclude that the dawn phenomenon contributed directly and significantly to the BG maximum and indirectly, in some cases, to nocturnal hypoglycemia. It thus played an important role in the intraday blood glucose variation of such patients.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6751733     DOI: 10.2337/diacare.4.6.579

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  37 in total

1.  Growth hormone controls lipolysis by regulation of FSP27 expression.

Authors:  Rita Sharma; Quyen Luong; Vishva M Sharma; Mitchell Harberson; Brian Harper; Andrew Colborn; Darlene E Berryman; Niels Jessen; Jens Otto Lunde Jørgensen; John J Kopchick; Vishwajeet Puri; Kevin Y Lee
Journal:  J Endocrinol       Date:  2018-12-01       Impact factor: 4.286

2.  Two or three insulin injections in adolescence?

Authors:  F R Hinde; D I Johnston
Journal:  Arch Dis Child       Date:  1986-02       Impact factor: 3.791

Review 3.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

4.  Bedtime insulin injections: an alternative regimen.

Authors:  F R Hinde; D I Johnston
Journal:  Arch Dis Child       Date:  1985-04       Impact factor: 3.791

Review 5.  Somatostatin.

Authors:  S R Bloom; J M Polak
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-01

Review 6.  Technology and the diabetic patient.

Authors:  J C Pickup; D Rothwell
Journal:  Med Biol Eng Comput       Date:  1984-09       Impact factor: 2.602

7.  Fasting hyperglycaemia in insulin dependent diabetics.

Authors:  M McEvoy; R Drury; A Keane; M McKeever; M I Drury
Journal:  Ir J Med Sci       Date:  1982-11       Impact factor: 1.568

8.  Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches.

Authors:  Ashwini Mallad; Ling Hinshaw; Chiara Dalla Man; Claudio Cobelli; Rita Basu; Ravi Lingineni; Rickey E Carter; Yogish C Kudva; Ananda Basu
Journal:  Diabetes Technol Ther       Date:  2015-06-29       Impact factor: 6.118

Review 9.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 10.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.